ReviewCellular and molecular life sciences : CMLS2003
The causes of Charcot-Marie-Tooth disease.
Review in Cellular and molecular life sciences : CMLS, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.
- Treatment for Charcot-Marie-Tooth disease.The Cochrane database of systematic reviews · 2008Pooled it
- Animal Models of CMT2A: State-of-art and Therapeutic Implications.Molecular neurobiology · 2020Review
- Rapamycin improves peripheral nerve myelination while it fails to benefit neuromuscular performance in neuropathic mice.Neurobiology of disease · 2014Article
- A probabilistic model to predict clinical phenotypic traits from genome sequencing.PLoS computational biology · 2014Article
- Rab7 mutants associated with Charcot-Marie-Tooth disease cause delayed growth factor receptor transport and altered endosomal and nuclear signaling.The Journal of biological chemistry · 2013Article
- Gap junction communication in myelinating glia.Biochimica et biophysica acta · 2013Review
- Rab proteins and the secretory pathway: the case of rab18 in neuroendocrine cells.Frontiers in endocrinology · 2011Article
- Functional and comparative genomics analyses of pmp22 in medaka fish.BMC neuroscience · 2009Article
- Role of immune cells in animal models for inherited peripheral neuropathies.Neuromolecular medicine · 2006Review
- Periaxin mutation in Japanese patients with Charcot-Marie-Tooth disease.Journal of human genetics · 2006Article
- [The role of the immune system in hereditary demyelinating neuropathies].Der Nervenarzt · 2005Review
- Pathology of a mouse mutation in peripheral myelin protein P0 is characteristic of a severe and early onset form of human Charcot-Marie-Tooth type 1B disorder.The Journal of cell biology · 2004Article
- Periaxin mutation causes early-onset but slow-progressive Charcot-Marie-Tooth disease.Journal of human genetics · 2004Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Charcot-Marie-Tooth (CMT) disease serves as the summary term for the most frequent forms of inherited peripheral neuropathies that affect motor and sensory nerves. In the last 12 years, 14 genes have been identified that cause different CMT subforms. The genes found initially are predominantly responsible for demyelinating and dysmyelinating neuropathies. Genes affected in axonal and rare forms of CMT have only recently been identified. In this review, we will focus on the currently known genes that are associated with CMT syndromes with regards to their genetics and function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.